Noah from Germany

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

AbbVie, Inc. (ABBV) shares information

AbbVie, Inc.

24h Change

-0.07 %


Live rate: Market closed

Stock data per Wednesday 8 Jul, 2020

New York Stock Exchange
-0.07 (-0.07%)
US Market is closed

Live Stock price in graph for AbbVie, Inc. (ABBV)

  • Latest Volume

    6,153,717 (-3.02 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change

    + 10.87 %

Quick links


Latest news about AbbVie, Inc.

Below you can find the most recent news posts about AbbVie, Inc., primarily from US and UK based news sources.

International trade judge suggests a 10-year ban on a Botox rival

Wednesday, 8 July 2020, 18:58:07
Allergan, which AbbVie recently acquired, had alleged that two companies stole trade secrets used to develop a rival to the best-selling Botox treatment.
— STAT News

AbbVie Remains One of the Safest Pharma Investments You Can Make

Wednesday, 8 July 2020, 15:01:40
The pharmaceutical market has its ups and downs, but that doesn’t mean every investment is risky as AbbVie stock is a reasonably safe bet.
— InvestorPlace

The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy

Wednesday, 8 July 2020, 13:31:40
Here’s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbVie Inc (NYSE: ABBV ) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) argenx SE – ADR (NASDAQ: ARGX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (FDA approved the cellulitis drug it had licensed to Endo International PLC (NASDAQ: ENDP )) Cerus Corporation (NASDAQ: CERS ) (announced study results demonstrating that its INTERCEPT Blood System inactivates SARS-CoV-2 in plasma components intended for transfusion) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) ( announced initiation of a Phase 1 study of a potential coronavirus treatment) Crispr Therapeutics AG (NASDAQ: CRSP ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Immunomedics, Inc.
— Benzinga

Better Buy: AbbVie vs. Biogen

Wednesday, 8 July 2020, 13:27:00
Which of these two drugmakers will outperform the other on the stock market moving forward?
— The Motley Fool

4 Top Stock Trades for Wednesday: LVGO, WMT, ABBV, NVAX

Tuesday, 7 July 2020, 22:46:54
AbbVie, Livongo, Walmart and Novavax were our top stock trades for Wednesday. That said, let’s look at the charts to see what’s going on.
— InvestorPlace